Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Immune reconstitution inflammatory syndrome in human immunodeficiency virus-infected children in Peru.

Wang ME, Castillo ME, Montano SM, Zunt JR.

Pediatr Infect Dis J. 2009 Oct;28(10):900-3. doi: 10.1097/INF.0b013e3181a4b7fa.

2.

Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort.

Ratnam I, Chiu C, Kandala NB, Easterbrook PJ.

Clin Infect Dis. 2006 Feb 1;42(3):418-27. Epub 2005 Dec 28.

3.

Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy.

Smith K, Kuhn L, Coovadia A, Meyers T, Hu CC, Reitz C, Barry G, Strehlau R, Sherman G, Abrams EJ.

AIDS. 2009 Jun 1;23(9):1097-107. doi: 10.1097/QAD.0b013e32832afefc.

4.
5.

Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children.

Puthanakit T, Oberdorfer P, Akarathum N, Wannarit P, Sirisanthana T, Sirisanthana V.

Pediatr Infect Dis J. 2006 Jan;25(1):53-8.

6.

The clinical pattern, prevalence, and factors associated with immune reconstitution inflammatory syndrome in Ugandan children.

Orikiiriza J, Bakeera-Kitaka S, Musiime V, Mworozi EA, Mugyenyi P, Boulware DR.

AIDS. 2010 Aug 24;24(13):2009-17. doi: 10.1097/QAD.0b013e32833b260a.

7.

Incidence, spectrum and outcome of immune reconstitution syndrome in HIV-infected children after initiation of antiretroviral therapy.

Gkentzi D, Tebruegge M, Tudor-Williams G, Walters S, Lyall H, Sharland M, Doerholt K.

Pediatr Infect Dis J. 2014 Sep;33(9):953-8. doi: 10.1097/INF.0000000000000331.

PMID:
24618936
8.

Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa.

Haddow LJ, Moosa MY, Mosam A, Moodley P, Parboosing R, Easterbrook PJ.

PLoS One. 2012;7(11):e40623. doi: 10.1371/journal.pone.0040623. Epub 2012 Nov 12.

9.

Immune reconstitution inflammatory syndrome in adult human immunodeficiency virus-infected patients in Thailand.

Aramaki M, Silachamroon U, Desakorn V, Maek-A-nantawat W, Waiwaruwut J, Jutiwarakun K, Kim JH, Pitisuttithum P.

Southeast Asian J Trop Med Public Health. 2010 Jan;41(1):138-45.

PMID:
20578492
10.

A study of TB-associated immune reconstitution inflammatory syndrome using the consensus case-definition.

Sharma SK, Dhooria S, Barwad P, Kadhiravan T, Ranjan S, Miglani S, Gupta D.

Indian J Med Res. 2010 Jun;131:804-8.

11.

Incidence of opportunistic illness before and after initiation of highly active antiretroviral therapy in children.

Nesheim SR, Hardnett F, Wheeling JT, Siberry GK, Paul ME, Emmanuel P, Bohannon B, Dominguez K; LEGACY Consortium.

Pediatr Infect Dis J. 2013 Oct;32(10):1089-95. doi: 10.1097/INF.0b013e31829ee893.

12.

Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.

Levin MJ, Anderson JP, Seage GR 3rd, Williams PL; PACTG/IMPAACT 219C Team.

J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):182-91. doi: 10.1097/QAI.0b013e31819550a4.

13.

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.

PMID:
11826235
14.

Later onset of herpes zoster-associated immune reconstitution inflammatory syndrome.

Espinosa E, Peña-Jiménez A, Ormsby CE, Vega-Barrientos R, Reyes-Terán G.

HIV Med. 2009 Aug;10(7):454-7. doi: 10.1111/j.1468-1293.2009.00700.x. Epub 2009 Mar 26.

15.

Tuberculosis Immune Reconstitution Inflammatory Syndrome in children initiating Antiretroviral Therapy for HIV infection: A systematic literature review.

Link-Gelles R, Moultrie H, Sawry S, Murdoch D, Van Rie A.

Pediatr Infect Dis J. 2014 May;33(5):499-503. doi: 10.1097/INF.0000000000000142. Review.

16.

Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.

Ravimohan S, Tamuhla N, Steenhoff AP, Letlhogile R, Nfanyana K, Bellamy SL, MacGregor RR, Gross R, Weissman D, Bisson GP.

Lancet Infect Dis. 2015 Apr;15(4):429-38. doi: 10.1016/S1473-3099(15)70008-3. Epub 2015 Feb 9. Erratum in: Lancet Infect Dis. 2015 May;15(5):505.

17.

The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.

Naidoo K, Yende-Zuma N, Padayatchi N, Naidoo K, Jithoo N, Nair G, Bamber S, Gengiah S, El-Sadr WM, Friedland G, Abdool Karim S.

Ann Intern Med. 2012 Sep 4;157(5):313-24. doi: 10.7326/0003-4819-157-5-201209040-00004.

18.

The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study.

Yang CH, Chen KJ, Tsai JJ, Lin YH, Cheng SH, Wang KF, Chiou HY.

BMC Infect Dis. 2014 Jun 4;14:304. doi: 10.1186/1471-2334-14-304.

19.

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy.

Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC Jr, Hamill RJ.

AIDS. 2005 Mar 4;19(4):399-406.

PMID:
15750393
20.

Immune reconstitution inflammatory syndrome among HIV/AIDS patients during highly active antiretroviral therapy in Addis Ababa, Ethiopia.

Huruy K, Mulu A, Mengistu G, Shewa-Amare A, Akalu A, Kassu A, Andargie G, Elias D, Torben W.

Jpn J Infect Dis. 2008 May;61(3):205-9.

Items per page

Supplemental Content

Write to the Help Desk